Increasing application of phospholipids in cosmetics and pharmaceutical industries, rising preference for functional and convenience foods, and growing use of phospholipids in supplements are some key factors expected to drive market growth
According to Emergen Research, the global phospholipids market size was USD 3.21 billion in 2020 and is expected to reach USD 4.81 billion in 2028 and register a revenue CAGR of 5.3% during the forecast period, 2021-2028.
Phospholipids are a crucial component of cell membranes and play a significant role in maintaining structure and functionality of biological membranes. Phospholipids also have metabolic functions that solubilize cholesterol and fatty components in food and drug substances. Phospholipid possess very low toxicity profile and can be used for various purposes such as for parenteral administration for solubilizing formulations, in liposomes for drug targeting and slow release, and for topical administration. Phospholipids have been widely used in topical, oral and parenteral drugs to improve bio-availability, reduced toxicity, and increased permeability across the membranes and this is a key factor expected to drive market revenue growth over the forecast period.
Claim Your FREE Sample Copy with Table of content@ https://www.emergenresearch.com/request-sample/809
Phospholipids are integral part of all cellular and sub-cellular membranes and form lipid bilayers. Phospholipids exert structural functions in cellular membranes depending on cell and organelle functions. Dietary phospholipids are derived from soybeans, egg yolk, milk, and fish. Structural diversity of phospholipids and variability in chemical and biophysical properties have led to extensive application of phospholipids in various pharmaceutical formulations. Phospholipids act as emulsifiers and are one of the main components of lecithin.
It is used as a food additive in many products. Dietary phospholipids have beneficial effects on different illnesses and symptoms such as coronary heart disease, cancer, or inflammation. Natural phospholipids are used in oral, dermal, and parenteral products, Phospholipids also help prevent accumulation of fats in the liver and this has boosted its application in treating fatty liver disease and maintaining normal function of liver. These key factors are expected to increase demand for phospholipids-based products and dietary supplements going ahead.
However, long-term side effects of phospholipids-based products such as excess sweating, nausea, diarrhea, inflammation or fibrosis, and skin irritation among others is a key factor expected to restrain market growth to a certain extent. In addition, limited research on phospholipids and their applications can further hamper market growth going ahead.
COVID-19 Impact Analysis
- The virus outbreak and social distancing norms and restrictions severely disrupted the overall business landscape and operations worldwide.
- COVID-19 pandemic and lockdowns have resulted in several countries shutting down airports, ports, and commercial and domestic transportation. This had impacted manufacturing activities and operations globally and took a toll on the economy of various countries.
- Sudden and drastic downturn in economic activity caused a slowdown in manufacturing, production, import/export, and other sectors and also resulted in employment loss to a major extent.
- Supply impacts were further compounded due to challenges on the demand-side owing to reduced disposable income, depleting savings, and increased concerns and uncertainties.
- Emergence of variants of the virus and rise in infection rates during the initial waves and subsequent lockdowns has severely impacted operations and disrupted supply chains.
Check Our Prices@ https://www.emergenresearch.com/select-license/809
Phosphatidylcholine Segment to Account for Largest Revenue Share:
Phosphatidylcholine segment is expected to account for largest revenue share over the forecast period attributable to increasing application of phosphatidylcholine such as in medications to treat conditions such as ulcerative colitis, Alzheimer’s disease, and memory loss, among others. Phosphatidylcholine is also used to dissolve fat in cosmetic injections and this is expected to further contribute to revenue growth of this segment.
Powder Segment to Register Rapid Revenue CAGR:
Powder segment is expected to register rapid revenue CAGR over the forecast period owing to increasing demand for powder-based products from food and pharmaceutical industries. In addition, phospholipid-based tablets, nutrients, and supplements are available in powder form and this is a key factor expected to fuel revenue growth of the powder segment.
Natural Segment to Register Significant Revenue Growth:
Natural segment is expected to register significant revenue growth over the forecast period attributed to increasing preference for organic and natural food products, rising focus of individuals on healthy diets, and growing demand for plant-based and animal-based ingredients.
Pharmaceutical Segment to Lead in Terms of Revenue:
Pharmaceutical segment is expected to dominate other application segments over the forecast period attributable to increasing application of phospholipids in drugs and therapeutics to treat several health conditions such as liver disease, cancer, and inflammation, among others. Phospholipids also facilitate targeted administration of a drug or a therapeutic and this is epecte to further boost revenue growth of the segment.
Asia Pacific to Register Robust Revenue CAGR:
Asia Pacific market revenue is expected to expand at a robust revenue CAGR over the forecast period owing to increasing demand for natural and organic food products, rising focus on healthier foods, and growing demand for functional foods and supplements.
Major Companies in the Market include:
- Archer Daniels Midland Company
- Cargill, Inc.
- Bunge Ltd.
- Avanti Polar Lipids, Inc.
- DowDuPont, Inc.
- Wilmar International Ltd.
- Berg + Schmidt GmbH & Co. KG
- Lipoid GmbH, Kewpie Corporation
- Sime Darby Unimills B.V.
Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends: https://www.emergenresearch.com/industry-report/phospholipids-market
For the purpose of this report, Emergen Research has segmented the global phospholipids on the basis of type, product type, source, function, application, and region:
Type Outlook (Revenue, USD Billion; 2018–2028)
- Phosphatidic Acid
- Phosphatidylinositol Phosphate
- Phosphatidylinositol Bisphosphate
- Phosphatidylinositol Trisphosphate
Product Type Outlook (Revenue, USD Billion; 2018–2028)
Source Outlook (Revenue, USD Billion; 2018–2028)
Function Outlook (Revenue, USD Billion; 2018–2028)
- Releasing Agent
- Binding Agent
Application Outlook (Revenue, USD Billion; 2018–2028)
- Personal Care
- Food & Feed
Regional Outlook (Revenue, USD Billion; 2018–2028)
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of APAC
- Latin America
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of MEA
Take a Look at our Related Reports:
Nanopharmaceutical Drugs Market By Type, By Application, By Distribution Channel, Forecasts to 2027
Clinical Perinatal Software Market By Product Type, By Deployment Mode, By Application, By End-User, Forecasts to 2027
Human Microbiome Modulators Market By Product (Prebiotics and Dietary Supplements, Probiotics and Creams, Drugs), By Application (Infections, Neurological Disorders, Cancers, Dermatological, Gastrointestinal, Metabolic), By Region Forecasts to 2027
In Silico Drug Discovery Market By Workflow (Discovery, Preclinical Tests, Clinical Trials), By Product (Consultancy as a Service, Software as a Service), By Type of Large Molecule, By End User (Contract Research Organizations, Pharmaceutical Industry), and By Region, Forecasts to 2027
Prenatal Testing Market By Method, Test-Type (Invasive, Non-Invasive) By Application (Microdeletions Symptoms, Trisomy, Others), By End-Use (Specialty Clinics, Hospitals, Diagnostic Centers), By Region Forecasts to 2027
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
Read Full Press Release: https://www.emergenresearch.com/press-release/global-phospholipids-market